Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Venous Thormboembolism × Enoxaparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 3 Venous Thromboembolism 3 Neoplasms 3 Pancreatic Neoplasms 2 Venous Thormboembolism 1 Thrombosis 1 Thromboembolism 1 Stroke 1 Soft Tissue Neoplasms 1 Sarcoma 1 Pulmonary Embolism 1 Ovarian Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Catheter-Related Infections 1 Carcinoma, Pancreatic Ductal 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02706249 2021-07-08

Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients

Dana-Farber Cancer Institute

Phase 2 Completed

50 enrolled 7 charts

Venous Thormboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡